Relationship between the kinetics of the anticoagulant effects of racemic warfarin and its individual enantiomers in man
Levy, G.; O'Reilly, R.A.; Wingard, L.B.
Research Communications in Chemical Pathology and Pharmacology 7(2): 359-365
1974
ISSN/ISBN: 0034-5164 PMID: 4594366 Document Number: 75099
Document emailed within 1 workday
Related Documents
Blaschke, G.; Kraft, H.P.; Fickentscher, K.; Köhler, F. 1979: Chromatographic separation of racemic thalidomide and teratogenic activity of its enantiomers Arzneimittel-Forschung 29(10): 1640-1642Shen, Y.; Yi, D-nian.; Liu, J-ning. 2002: Discussion of the application of three-point interaction principle to the phenylglycine racemic compound in IR spectrometry and its enantiomers separation in HPLC Yao Xue Xue Bao 37(8): 636-638
Hyun, M.H.; Koo, H.J.; Lee, G.S.; Han, S.C. 2000: Effect of the double bond pi-conjugation of the aromatic group of racemic analytes on the liquid chromatographic separation of enantiomers Enantiomer 5(5): 499-503
Yacobi, A.; Lai, C.M.; Levy, G. 1984: Pharmacokinetic and pharmacodynamic studies of acute interaction between warfarin enantiomers and chloramphenicol in rats Journal of Pharmacology and Experimental Therapeutics 231(1): 80-84
Bürgisser, E.; Lefkowitz, R.J.; DeLean, A. 1981: Alternative explanation for the apparent "two-step" binding kinetics of high-affinity racemic antagonist radioligands Molecular Pharmacology 19(3): 509-512
Scott, E.A.; Sandler, G.A.; Byars, T.D. 1978: Warfarin: effects of intravenous loading doses and vitamin K on warfarin anticoagulation in the pony American Journal of Veterinary Research 39(12): 1888-1891
Davis, L.J.; Kayser, S.R.; Hubsher, J.; Williams, R.L. 1984: Effect of oxaprozin on the steady-state anticoagulant activity of warfarin Clinical Pharmacy 3(3): 295-297
Yang, P.; Wu, Q.-H.; Luo, X.-Y.; Kou, L.; Chen, Z.; Zhang, Y.-Y.; Zhou, H. 2009: The study of Chinese optimal anticoagulant range of warfarin for venous thromboembolism Zhonghua Yi Xue Za Zhi 89(25): 1762-1765
Amián, A.; Rodríguez, J.N.; Muñiz, R.; Diéguez, J.C.; Moreno, M.V.; Quesada, J.A.; Cañavate, M.; Fernández-Jurado, A.; Martino, M.L.; Prados, D. 1996: Comparative study of the stability of oral anticoagulant treatments (warfarin vs acenocoumarol) Sangre 41(1): 9-11
Kinzner, C.L. 1998: Warfarin sodium (Coumadin) anticoagulant Therapy for vascular access patency Anna Journal 25(2): 195-203; Quiz 204, 209
Pattacini, C.; Manotti, C.; Pini, M.; Quintavalla, R.; Dettori, A.G. 1994: A comparative study on the quality of oral anticoagulant therapy (warfarin versus acenocoumarol) Thrombosis and Haemostasis 71(2): 188-191
Islam, M.S.; Islam, M.A.; Azad, A.K.; Banerjee, S.K.; Ahmed, C.M.; Haque, H.; Ahmed, M.K.; Rumki, R.S.; Mahmood, M.; Rashid, F.B. 2016: Use of Anticoagulant Warfarin in Patients Presenting with Atrial Fibrillation in a Tertiary Level Hospital Mymensingh Medical Journal: Mmj 25(3): 523-529
Olteanu, H.; Downes, K.A.; Patel, J.; Praprotnik, D.; Sarode, R. 2009: Warfarin Does Not Interfere with Lupus Anticoagulant Detection by Dilute Russell’s Viper Venom Time Clinical Laboratory 55(3-4): 138-142
Marutaka, M.; Kubota, Y.; Yoshida, R.; Orita, Y. 2009: Difficult management of warfarin anticoagulant therapy due to S-1 administration for gastric cancer--report of a case Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(9): 1561-1563
Strain, J.; Templeton, K. 2013: Is Apixaban (Eliquis) the "ideal" anticoagulant to replace warfarin for stroke prevention in atrial fibrillation? South Dakota Medicine: the Journal of the South Dakota State Medical Association 66(1): 20-21
Vanhaelen, M.; Vanhaelen-Fastré, R. 1978: Stability of anticoagulant derivatives of 4-hydroxycoumarin. II. Structure of the principal degradation products of phenprocoumin, Clocoumarol, warfarin and acenocoumarin Pharmaceutica Acta Helvetiae 53(8): 221-230
Suwanawiboon, B.; Kongtim, P.; Chinthammitr, Y.; Ruchutrakool, T.; Wanachiwanawin, W. 2011: The efficacy of 3-mg warfarin initiating dose in adult Thai patients, who required long-term anticoagulant therapy Journal of the Medical Association of Thailand 94(Suppl 1): S225-S231
Piquette-Miller, M.; Jamali, F. 1995: Influence of severity of inflammation on the disposition kinetics of propranolol enantiomers in ketoprofen-treated and untreated adjuvant arthritis Drug Metabolism and Disposition: the Biological Fate of Chemicals 23(2): 240-245
Vainieri, H.; Wingard, L.B. 1977: Effect of warfarin on the kinetics of the vitamin K-dependent clotting factors in rats Journal of Pharmacology and Experimental Therapeutics 201(2): 507-517
Sychev, D.A.; Antonov, I.M.; Ignat'ev, I.V.; Naumova, I.V.; Dmitriev, V.A.; Kropacheva, E.S.; Dobrovol'skiĭ, O.B.; Panchenko, E.P.; Tashenova, I.A.; Kukes, V.G. 2010: Anticoagulant action and safety of warfarin dosing based on pharmacogenetic testing: results of the first Russian prospective pilot study Kardiologiia 50(5): 42-46